Alk-Abello targets China's growing allergy market, inks Eddingpharm deal
SHANGHAI – Alk-Abello A/S has signed a deal in which up and comer specialty pharmaceutical, Eddingpharm Co. Ltd., will handle the sales and distribution of Alk's allergy immunotherapy treatment here, products it hs been selling under its own steam since 2005.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST